You are here:
Our board of experts, the Pharmaceutical Benefits Board, makes most of the decisions on pricing and reimbursement. Our decisions are based on a number of factors, including the fundamental principles of the health care system.
The Pharmaceutical Benefits Board makes reimbursement and pricing decisions for new:
The Director-General of TLV make reimbursement decisions regarding:
Our decisions issue from the Act on Pharmaceutical Benefits as well as the overarching goal of promoting good health and equal access to healthcare.
We take into account three fundamental principles:
Before we make a decision, the region councils are entitled to review the company's application along with our decision materials. The applying company can also access our information material in regard to the decision.
We weigh the benefit of a medicine against its cost. All positive effects on human health are analysed with respect to cost in order to ensure that a medicinal product is cost-effective to use. We also take the solidarity principle and the human value principle into account when making our decisions.
Last updated 16 juni 2020